XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities    
Net Loss $ (10,506,001) $ (9,151,370)
Non-Cash Adjustments    
Depreciation and Amortization 422,931 517,412
Amortization of Software Development Costs and Prepaid Licenses in Cost of Sales - Products 60,099 60,099
Stock-Based Compensation 4,319,748 4,618,213
Impairment of Patents and Trademarks 49,603 27,731
Loss on Fixed Asset Disposal   83,908
(Increase) Decrease in Operating Assets    
Accounts Receivable 690,775 91,973
Revenues in Excess of Billings   (40,856)
Inventories (407,084) (857,695)
Manufacturing Vendor Prepayments (82,513) (1,785,763)
Prepaid Expenses and Other Assets 213,394 142,685
Increase (Decrease) in Operating Liabilities    
Accounts Payable (831,021) (191,028)
Accrued Expenses (292,286) 646,048
Unearned Revenue 1,825 (17,698)
Income and Other Taxes (74,549) (65,288)
Net Cash Flows Used in Operating Activities (6,435,079) (5,921,629)
Cash Flows from Investing Activities    
Purchases of Fixed Assets (57,758) (314,981)
Investments in Patents and Trademarks (34,469) (135,674)
Investments in Licenses, Intangible and Other Assets (125,000) (200,000)
Net Cash Flows Used in Investing Activities (217,227) (650,655)
Cash Flows from Financing Activities    
Proceeds from Exercise of Warrants   34,568,538
Proceeds from Exercise of Stock Options 29,224 196,828
Proceeds from Common Stock Offering, Net   79,603,872
Preferred Dividend Settlement Payment   (10,000,000)
Employee Tax Withholdings Payment   (1,144,366)
Purchases of Treasury Stock (251,057)  
Net Cash Flows Provided from Financing Activities (221,833) 103,224,872
Net Increase in Cash and Cash Equivalents (6,874,139) 96,652,588
Cash and Cash Equivalents - Beginning of Period 120,203,873 36,069,508
Cash and Cash Equivalents - End of Period 113,329,734 132,722,096
Supplemental Disclosures    
Unamortized Common Stock Expense included in Prepaid Expenses and Other Assets 1,001,232 160,222
Stock-Based Compensation Expense - Expensed less Previously Issued $ 364,010 $ 58,828